Bristol-Myers Squibb Company BMY

Bristol-Myers Squibb (BMY) is an international pharmaceutical company that specializes in the development and production of medicinal products for the treatment of various diseases, including oncology, cardiology, immunology, and other areas of medicine. The company was founded in 1858 and has its headquarters in New York.

Bristol-Myers Squibb is a leader in the pharmaceutical industry and has a wide range of products, including well-known brands such as Opdivo, Eliquis, Orencia, and Sprycel. It is also actively engaged in research and development of new medicinal products to help patients with various diseases.

The company aims to be socially responsible and sustainable and has set ambitious goals to reduce its impact on the environment. It also supports numerous philanthropic programs, including programs to combat cancer and other diseases.

However, like any pharmaceutical company, BMY faces criticism from those who claim that drug prices are too high and that the company is not doing enough to ensure accessibility of drugs for all patients. The company claims to be working on addressing this issue and striving to make its products more accessible to everyone.

Overall, Bristol-Myers Squibb is a large and respected pharmaceutical company that is actively engaged in developing medicinal products for the treatment of various diseases. It also aims to be socially responsible and sustainable and supports numerous philanthropic programs. However, the company faces challenges related to drug accessibility for all patients and is working on addressing this issue.